共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
Alfredo Giuseppe Cerillo MD Daniel Griese MD Sergio Berti MD 《Catheterization and cardiovascular interventions》2016,88(2):319-323
Transcatheter aortic valve implantation (TAVI) was initially developed for the treatment of calcific aortic stenosis. In the recent years, however, TAVI has been used to treat selected patients with pure, severe AR. We report successful transfemoral implantation of a Symetis ACURATE neo bioprosthesis in a severely symptomatic, 87‐year‐old woman with pure AR and major comorbidities. We decided to use the ACURATE neo bioprosthesis for some of its features appeared to us as potentially useful in the setting of pure AR: the stabilization arches ensure perfect coaxial alignment and extreme stability of the device during deployment, and the “waist” and the skirt were considered useful to obtain a good seal in the absence of significant valvular and annular calcifications. Finally, we decided to use a self‐expanding valve to minimize the trauma to the aortic annulus. The procedure was successful and the patient was discharged home on postoperative day 3. At the 3‐month control echocardiography, there was no residual AR, and the mean transprosthetic gradient was 3 mm Hg. The current case demonstrates that percutaneous TAVI with the ACURATE neo bioprosthesis may be used to treat pure, isolated AR in selected patients. The device has several interesting features that could make it advantageous in this setting. © 2016 Wiley Periodicals, Inc. 相似文献
3.
Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval 下载免费PDF全文
Michael N. Young MD Sammy Elmariah MD MPH Kevin F. Kennedy MS Ignacio Inglessis MD Robert W. Yeh MD MSC 《Catheterization and cardiovascular interventions》2017,90(5):830-838
4.
Ignacio J. Amat‐Santos Hiplito Gutirrez Janarthanan Sathananthan John G Webb 《Catheterization and cardiovascular interventions》2020,95(4):E120-E122
Valve‐in‐valve (ViV) transcatheter procedures have emerged as a feasible, less‐invasive treatment option for bioprosthetic structural valve deterioration. However, in the presence of a small bioprosthesis, a significant residual gradient after ViV procedures often occurs and has been associated with poorer clinical outcomes. We report the use of the self‐expandable supra‐annular ACURATE neo? valve to treat degenerated Mitroflow (Sorin) aortic bioprosthesis with severe residual elevated gradients followed by valve fracture with a postdilation using a noncompliant balloon leading to significant reduction in residual gradients. In conclusion, the use of ACURATE neo? valve followed by the controlled fracture of the surgical bioprosthesis frame with a noncompliant balloon is a safe and effective approach for patients with Mitroflow® failing valves and residual elevated gradient after transcatheter aortic valve replacement. 相似文献
5.
Outcomes and predictors of mortality after transcatheter aortic valve implantation: Results of the Brazilian registry 下载免费PDF全文
Fbio S. de Brito Luiz A. Carvalho Rogrio Sarmento‐Leite Jos A. Mangione Pedro Lemos Alexandre Siciliano Paulo Caramori Luiz So Thiago Eberhard Grube Alexandre Abizaid 《Catheterization and cardiovascular interventions》2015,85(5):E153-E162
6.
7.
Ehud Jacobzon Arik Wolak Danny Fink Shuli Silberman 《Catheterization and cardiovascular interventions》2019,93(7):E391-E393
We report a case of a 78‐year‐old female who presented with type A aortic dissection 22 months following transcatheter aortic valve implantation (TAVI). In addition, preoperative echocardiogram showed high gradients across the aortic prosthesis which was found to be thrombosed. At surgery, the intimal tear appeared to be non‐acute and anatomically related to the rim of the valve cage. The thrombosed valve was not replaced and the patient received anticoagulation therapy following surgery with significant improvement in valve gradients. 相似文献
8.
Reversible thrombotic aortic valve restenosis after valve‐in‐valve transcatheter aortic valve replacement 下载免费PDF全文
Patrick J. Goleski MD Mark Reisman MD Creighton W. Don MD 《Catheterization and cardiovascular interventions》2018,91(1):165-168
Thrombotic aortic valve restenosis following transcatheter aortic valve replacement (TAVR) has not been extensively reported and the rates of TAVR valve thrombosis are not known. We present three cases of valve‐in‐valve (VIV) restenosis following TAVR with the balloon expandable transcatheter heart valves, presumably due to valve thrombosis that improved with anticoagulation. © 2016 Wiley Periodicals, Inc. 相似文献
9.
10.
Complete filter‐based cerebral embolic protection with transcatheter aortic valve replacement 下载免费PDF全文
Lennart Van Gils MD Herbert Kroon MD Joost Daemen MD PhD Claire Ren MD PhD Anne‐Marie Maugenest RN Marguerite Schipper MD PhD Peter P. De Jaegere MD PhD Nicolas M. Van Mieghem MD PhD 《Catheterization and cardiovascular interventions》2018,91(4):790-797
11.
12.
Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience 下载免费PDF全文
Maurizio Taramasso MD Shingo Kuwata MD Hans Rickli MD Philipp K. Haager MD Gabor Sütsch MD Hector Rodriguez Cetina Biefer MD Jan Kottwitz MD Fabian Nietlispach MD PhD Francesco Maisano MD 《Catheterization and cardiovascular interventions》2018,91(3):533-539
13.
Giulia Costa MD Nikolaj Ihlemann MD PhD Lars Søndergaard MD DMSc Ole De Backer MD PhD 《Catheterization and cardiovascular interventions》2021,97(5):E736-E738
Aortic annulus rupture or aortic root perforation is a rare complication of transcatheter aortic valve replacement (TAVR), requiring emergent cardiac surgery and carrying a high intraoperative mortality. Few cases can be managed conservatively, provided a strict clinical follow-up. This study describes the case of a 78-year-old patient with a degenerated bicuspid aortic valve stenosis who presented with a late aortic root perforation following TAVR, which was successfully managed applying a “watchful waiting” approach. Cardiac computed tomography imaging played a pivotal role in the diagnosis and subsequent decision on treatment and clinical follow-up. 相似文献
14.
15.
Procedural and 30‐day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study 下载免费PDF全文
Rocco A. Montone Luca Testa Chiara Fraccaro Matteo Montorfano Fausto Castriota Roberto Nerla Marco Angelillis Maurizio Tusa Francesco Giannini Andrea Garatti Giuseppe Tarantini Anna Sonia Petronio Nedy Brambilla Francesco Bedogni 《Catheterization and cardiovascular interventions》2017,90(7):1206-1211
16.
Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction 下载免费PDF全文
A.R. Harper MSc MBBS MRCP S. Dawkins BSc MBBS MRCP DPhil J.D. Newton MBChB MRCP MD 《Catheterization and cardiovascular interventions》2018,91(7):E72-E74
Transcatheter aortic valve implantation (TAVI) has transformed the treatment of severe aortic stenosis. Here, we present a case of late aortic root rupture presenting as ST‐elevation myocardial infarction five weeks following successful TAVI. Aortic root rupture is a rare complication of TAVI, which occurs in ~1% of procedures and usually arises during or soon after the procedure and is associated with high mortality (~50%). Early recognition of late‐presenting complications related to TAVI, including aortic root rupture, is essential for specialists and nonspecialists. © 2016 Wiley Periodicals, Inc. 相似文献
17.
18.
Simultaneous transapical transcatheter aortic valve replacement and transcatheter mitral valve replacement for native valvular stenosis 下载免费PDF全文
Ali Elkharbotly MD Augustin Delago MD Mohammad El‐Hajjar MD 《Catheterization and cardiovascular interventions》2016,87(7):1347-1351
Transcatheter aortic valve replacement (TAVR) is well established for patients who cannot undergo surgery (Leon et al., N Engl J Med 2010;363:1597) or are high risk for surgery (Smith et al., N Engl J Med 2011;364:2187–2198). Experience with the TAVR procedure has led to recent reports of successful transcatheter mitral valve replacement (TMVR) procedures (Cheung et al., J Am Coll Cardiol 2014;64:1814; Seiffert et al., J Am Coll Cardiol Interv 2012;5:341–349) separately or simultaneously with the TAVR. However, these reports were of simultaneous valve‐in‐valve procedures (Cheung Anson, et al. J Am Coll Cardiol 2013;61:1759–1766). A recent report from Portugal also reported simultaneous transpical implantation of an inverted transcatheter aortic valve‐in‐ring in the mitral position and transcatheter aortic valve (Hasan et al., Circulation 2013;128:e74–e76). There has been an experience of TMVR only in native mitral valve for mitral valve stenosis, but none in both aortic and mitral valves. We report the first in human case of simultaneous transapical TAVR and TMVR in native valves secondary to valvular stenosis. Our patient was not a candidate for percutaneous balloon mitral valvuloplasty secondary to a high Wilkins Score. Sizing of the aortic valve was based on the transesophageal echocardiogram (TEE), whereas sizing of the mitral valve was based on TEE measurements and balloon inflation during left ventriculography. © 2015 Wiley Periodicals, Inc. 相似文献
19.
Comparison of acute elastic recoil between the SAPIEN‐XT and SAPIEN valves in transfemoral–transcatheter aortic valve replacement 下载免费PDF全文
Shikhar Agarwal MD MPH Olcay Aksoy MD Muhammad Hammadah MD Kanhaiya Lal Poddar MD Rishi Puri MD Lars G. Svensson MD PhD Amar Krishnaswamy MD E. Murat Tuzcu MD FACC Samir R. Kapadia MD FACC 《Catheterization and cardiovascular interventions》2015,85(3):490-496
- Complex arch anatomy (type 2, type 3) and bovine configuration were identified in 34.4% and 20.5% of carotid stent patients, respectively.
- Catheter manipulation time (CMT), rather than arch complexity per se, was the only independent predictor of adverse events after carotid stenting.
- Careful attention to patient selection, preprocedural planning, and stent technique are important to ensure success.
20.
First report of a simultaneous transcatheter mitral valve‐in‐valve and aortic valve replacement in a left ventricular assist device patient 下载免费PDF全文
Christopher Meduri MD MPH James Kauten MD Mani Vannan MD Vivek Rajagopal MD 《Catheterization and cardiovascular interventions》2017,90(3):526-529
Transcatheter aortic valve replacement is standard of care for patients with severe aortic stenosis at high risk for surgical aortic valve replacement. Although not intended for treatment of primary aortic insufficiency, several transcatheter aortic valve prostheses have been used to treat patients with severe aortic insufficiency (AI), including patients with left ventricular assist devices (LVAD), in whom significant AI is not uncommon. Similarly, transcatheter valve replacements have been used for valve‐in‐valve treatment, in the pulmonary, aortic, and mitral positions, either via a retrograde femoral approach or antegrade transseptal approach (mitral valve‐in‐valve). In this case report, we report an LVAD patient with severe aortic insufficiency and severe bioprosthetic mitral prosthetic stenosis, in whom we successfully performed transfemoral aortic valve replacement and transfemoral mitral valve‐in‐valve replacement via a transseptal approach. © 2017 Wiley Periodicals, Inc. 相似文献